{"DataElement":{"publicId":"2741578","version":"1","preferredName":"During Collection Hematopoietic Stem Cell Graft Combined Anticoagulant Agent Additive Type","preferredDefinition":"A description of the anticoagulants that were added to the hematopoietic cell graft during collection.","longName":"DR_HSCT_INF_ANCO_TY","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2740650","version":"1","preferredName":"During Collection Hematopoietic Stem Cell Graft Combined Anticoagulant Agent","preferredDefinition":"At some point in a given period of time._The act of gathering things together; having been brought together in one place._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc)._Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._Made or joined or united into one or involving the joint activity of two or more._A drug that helps prevent blood clots from forming. Also called a blood thinner.","longName":"DR_HSCT_COB_ANCO","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2794370","version":"1","preferredName":"During Collection Hematopoietic Stem Cell Graft","preferredDefinition":"At some point in a given period of time.:The act of gathering something together.:Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.","longName":"C25490:C25453:C12551:C12981","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"During","conceptCode":"C25490","definition":"At some point in a given period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59CB36D3-7CEB-63FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-21","modifiedBy":"ONEDATA","dateModified":"2008-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2740646","version":"1","preferredName":"Combined Anticoagulant Agent","preferredDefinition":"Made or joined or united into one or involving the joint activity of two or more.:Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.","longName":"C25454:C263","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined","conceptCode":"C25454","definition":"Made or joined or united into one or involving the joint activity of two or more.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4ADB4BC7-83DD-3853-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-14","modifiedBy":"ONEDATA","dateModified":"2008-04-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4ADB4BC7-83EE-3853-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-14","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2739611","version":"1","preferredName":"Additive Type","preferredDefinition":"A substance that is added to a system or compound to improve its characteristics._Something distinguishable as an identifiable class based on common qualities.","longName":"ADDI_TY","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Antibiotic","valueDescription":"Antibiotic","ValueMeaning":{"publicId":"2574589","version":"1","preferredName":"Antibiotic","longName":"2574589","preferredDefinition":"(an-tih-by-AH-tik) A drug used to treat infections caused by bacteria and other microorganisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Antibiotic","conceptCode":"C258","definition":"Substances naturally produced by microorganisms or their derivatives that selectively target microorganisms not humans. Antibiotics kill or inhibit the growth of microorganisms by targeting components of the microbial cell absent from human cells, including bacterial cell walls, cell membrane, and 30S or 50S ribosomal subunits. These substances are used in the treatment of bacterial and other microbial infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F06A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-26","modifiedBy":"ONEDATA","dateModified":"2005-04-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"4A894181-3E2E-24CB-E044-0003BA3F9857","beginDate":"2008-04-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"ZHANGW","dateModified":"2008-04-10","deletedIndicator":"No"},{"value":"Dextran","valueDescription":"Dextran Sulfate Sodium","ValueMeaning":{"publicId":"2739613","version":"1","preferredName":"Dextran Sulfate Sodium","longName":"2739613","preferredDefinition":"The sodium salt of sulfuric acid esters of glucose polymers.  Dextran is produced by the action of the bacterium Leuconostoc mesenteroides and of other microorganisms on sucrose.  This agent possesses strong hydrophilic properties and binds to various membranes, particularly those with a positive charge. (NCI04)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dextran Sulfate Sodium","conceptCode":"C1284","definition":"A long chain polymer of sulfated glucose with strong hydrophilic properties that binds to various membranes. Dextran sulfate has been shown to inhibit the binding of HIV-1 to CD4+ T lymphocytes by specific binding of virion-associated gp120.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A894181-3E3C-24CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"4A894181-3E55-24CB-E044-0003BA3F9857","beginDate":"2008-04-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"ZHANGW","dateModified":"2008-04-10","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"4A894181-3E6D-24CB-E044-0003BA3F9857","beginDate":"2008-04-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"ZHANGW","dateModified":"2008-04-10","deletedIndicator":"No"},{"value":"Acid-Citrate-Dextrose (ACD)","valueDescription":"Acid-Citrate-Dextrose","ValueMeaning":{"publicId":"2739612","version":"1","preferredName":"Acid-Citrate-Dextrose","longName":"2739612","preferredDefinition":"A citrate anticoagulant used for the collection and preservation of whole blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acid-Citrate-Dextrose","conceptCode":"C63375","definition":"A solution of citric acid, sodium citrate, and dextrose used as an anticoagulant in the collection and preservation of whole blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A894181-3DFD-24CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"4A8A7DF5-B863-64DC-E044-0003BA3F9857","beginDate":"2008-04-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"ZHANGW","dateModified":"2008-04-10","deletedIndicator":"No"},{"value":"Citrate Phosphate Dextrose (CPD)","valueDescription":"Citrate Phosphate Dextrose","ValueMeaning":{"publicId":"2747083","version":"1","preferredName":"Citrate Phosphate Dextrose","longName":"2747083","preferredDefinition":"A solution of citric acid, sodium citrate, monobasic  sodium phosphate, and dextrose in water used as an anticoagulant in the  collection and preservation of whole blood.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Citrate Phosphate Dextrose","conceptCode":"C71605","definition":"A solution of citric acid, sodium citrate, monobasic sodium phosphate, and dextrose in water used as an anticoagulant in the collection and preservation of whole blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C926488-BE3F-129F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"4C926488-BE58-129F-E044-0003BA3F9857","beginDate":"2008-04-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-05-06","modifiedBy":"ZHANGW","dateModified":"2008-05-06","deletedIndicator":"No"},{"value":"Albumin","valueDescription":"ALBUMIN","ValueMeaning":{"publicId":"2561870","version":"1","preferredName":"ALBUMIN","longName":"2561870","preferredDefinition":"ALBUMIN","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Albumin","conceptCode":"C214","definition":"A family of globular proteins found in many plant and animal tissues that tend to bind a wide variety of ligands.  Albumin is the main protein in blood plasma.  Low serum levels occur in conditions associated with malnutrition, inflammation and liver and kidney diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BEBB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-22","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DB74FFB-DD3C-D969-E040-BB89A6435482","beginDate":"2008-12-10","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-10","modifiedBy":"CDECURATE","dateModified":"2008-12-10","deletedIndicator":"No"},{"value":"Heparin","valueDescription":"Heparin","ValueMeaning":{"publicId":"2567254","version":"1","preferredName":"Heparin","longName":"2567254","preferredDefinition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heparin","conceptCode":"C539","definition":"A sulfur-rich glycosaminoglycan with anticoagulant property. Heparin binds to antithrombin III to form a heparin-antithrombin III complex. The complex binds to and irreversibly inactivates thrombin and other activated clotting factors, such as factors IX, X, XI, and XII, thereby preventing the polymerization of fibrinogen to fibrin and the subsequent formation of clots.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3C3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5DB74FFB-DD4A-D969-E040-BB89A6435482","beginDate":"2008-12-10","endDate":null,"createdBy":"CDECURATE","dateCreated":"2008-12-10","modifiedBy":"CDECURATE","dateModified":"2008-12-10","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2793922","version":"1","preferredName":"Additive Type","preferredDefinition":"A substance that is added to a system or compound to improve its characteristics.:Type; a subdivision of a particular kind of thing.","longName":"C63495:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additive","conceptCode":"C63495","definition":"A substance that is added to a system or compound to improve its characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59506A62-F796-5D18-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-15","modifiedBy":"ONEDATA","dateModified":"2008-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A894181-3DE6-24CB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-10","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-10","modifiedBy":"ZHANGW","dateModified":"2011-04-13","changeDescription":"Updated the permissible value for CPD. 4/13/11: added alt definition for PV\"albumin\".wz","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964920","version":"1","longName":"2006r1: HSCT Infusion","context":"NHLBI"},{"publicId":"3191905","version":"1","longName":"2007r1:Cord Blood Unit -SCTOD Data Requirements","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"MaterialName:name","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What anticoagulants were adde","type":"Preferred Question Text","description":"What anticoagulants were added to the product during collection?","url":null,"context":"NHLBI"},{"name":"BRIDG mapping for CDE:2741578","type":"BRIDG Mapping Path","description":"PerformedSubstanceExtraction > Biologic [harvested product] > Subject > PerformedMaterialProcessStep [post-collection processing] > Product [additive used in processing] > MaterialName.name WHERE PerformedMaterialProcessStep > DefinedMaterialProcessStep.nameCode = \"add additive\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AED20EF-80CE-5F53-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-15","modifiedBy":"KUMMEROA","dateModified":"2021-06-17","changeDescription":". 2021-6-17 ak System generated def displayed as alt def. 1/8/14mn-added Bridg info.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}